Mineral rights owner Black Stone Minerals (NYSE:BSM) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 6.6% year on ye...
Food processing and aviation equipment manufacturer JBT Marel (NYSE:JBTM) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.9% year on yea...
Stoke Therapeutics (NASDAQ:STOK) said its Phase III EMPEROR study of zorevunersen in patients with Dravet syndrome remains on track for a data readout in the third quarter of 2027, following completion of enrollment ahead of the company’s planned rolling new drug application submission.
The global,
Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) reported second-quarter fiscal 2026 revenue of $189.6 million, up 113% from a year earlier, as growth accelerated across its direct-to-consumer and third-party agency channels. The company also raised its full-year revenue and adjusted EBITD
Palantir Technologies (NASDAQ:PLTR) reported second-quarter 2026 revenue growth of 93% year over year to $1.935 billion, driven by accelerating demand in its U.S. commercial and government businesses. The company also raised its full-year revenue, operating-income and free-cash-flow outlooks.
Chief
SiBone (NASDAQ:SIBN) reported second-quarter 2026 revenue growth of 15.2% and narrowed its net loss as procedure volumes increased across its U.S. business and international demand rose for its expanded product portfolio.
Worldwide revenue reached $56 million for the quarter ended June 30, while U.
ClearPoint Neuro (NASDAQ:CLPT) reported second-quarter 2026 revenue growth while outlining a shift in investment priorities toward clinical capacity, preclinical laboratory services and technologies intended to support commercial-scale neuro drug delivery.
Total revenue for the three months ended J
EverQuote (NASDAQ:EVER) reported second-quarter 2026 revenue growth of 25% year over year to $195.1 million, while adjusted EBITDA rose 37% to a record $30.1 million. The company said demand from both insurance carriers and local agents remained strong as carriers focused on expanding policies in fo
Ichor (NASDAQ:ICHR) reported second-quarter revenue of $294.8 million, up 15% sequentially, as demand strengthened across semiconductor equipment markets and the company continued efforts to expand internal manufacturing and improve margins.
The company said isolated part shortages late in the quar
Jazz Pharmaceuticals (NASDAQ:JAZZ) reported second-quarter 2026 revenue of $1.21 billion, up 16% from a year earlier, as growth across its sleep, epilepsy and oncology portfolios drove record quarterly sales. The company raised its full-year revenue outlook and said it is preparing for a potential A
Adeia (NASDAQ:ADEA) reported second-quarter 2026 revenue of $96.1 million and adjusted EBITDA of $56.4 million, producing an adjusted EBITDA margin of 59%. The intellectual-property licensing company said results were in line with its expectations and reiterated full-year revenue guidance of $395 mi
Advanced Energy Industries (NASDAQ:AEIS) reported record second-quarter results that exceeded its guidance, citing stronger demand across semiconductor, data center computing, industrial and medical markets and factory execution that enabled it to capture upside during the period.
Revenue rose 30%
Digital media conglomerate People (NASDAQGS:PPLI) announced better-than-expected revenue in Q2 CY2026, but sales fell by 13.5% year on year to $436.7 million...
Medical products company UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 15.1% year on y...
Oil and gas producer Crescent Energy (NYSE:CRGY) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 55.3% year on year to $1...
Consumer products giant Clorox (NYSE:CLX) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 2% year on year to $1.95 bi...
